知镜 Cognispect · 医学文献与研究工作台

Association of the ANCA Kidney Risk Score With Kidney Failure in Anti-Glomerular Basement Membrane Disease.

Caillard P, Vigneau C, Halimi JM, Hazzan M, Thervet E, Heitz M, Juillard L, Audard V, Rabant M, Hertig A, Brilland B, Vuiblet V, Guerrot D, Tamain M, Essig M, Lobbedez T, Quemeneur T, Legendre M, Ganea A, Peraldi MN, Vrtovsnik F, Daroux M, Choukroun G, Titeca-Beauport D.
Kidney international reports · 2026-10-06 · PMID 43017096

文献摘要

Introduction Anti-glomerular basement membrane (anti-GBM) disease is a rare vasculitis that is characterized by a poor renal prognosis. Despite the high predictive accuracy of the improved antineutrophil cytoplasmic autoantibody (ANCA) Kidney Risk Score (AKRiS) in ANCA-associated vasculitis, its prognostic value in anti-GBM disease remains to be established. Methods In this multicenter retrospective study, 163 biopsy-proven patients with anti-GBM were included. AKRiS was calculated at diagnosis, stratifying patients into low-, moderate-, high-, and very high-risk groups. The Fine-Gray model was used for the analysis of 36-month kidney failure, with the predictive performance assessed via Harrell C-index. Results The median AKRiS was 18 [11-21], with 69% of patients classified as high or very high-risk. The 36-month cumulative incidence of kidney failure was significantly higher in the high-risk (92% [95% confidence interval (CI), 82-97]) and very high-risk (98% [95% CI, 86-100]) groups, when compared with the low-risk (40% [95% CI, 19-61]; P P = 0.02). Despite higher AKRiS scores, double-positive patients had similar 36-month kidney failure compared with single-positive patients, reflecting their divergent pathophysiological and therapeutic responsiveness. Conclusion AKRiS is associated with renal risk in anti-GBM disease, irrespective of ANCA status. Its predictive performance further improves when combined with oligoanuria, supporting the development of pragmatic prognostic models for anti-GBM disease.

在知镜精读原文来源DOI 原文

知镜提供医学文献检索、阅读笔记、人体图谱、统计绘图与研究复现工具。